LOREN T.GREEN, Ph.D.Psychologist
Education:
United States International University, SD, CA Ph.D. 6/6/2001 Clinical Psychology
United States International University, SD, CA M.A. 10/31/94 Psychology
Chico State University, Chico, CA B.A. 1992 Psychology
Qualifications:
Wide range of experience working with culturally diverse children, adolescents and adult and senior adult populations at inpatient psychiatric facilities with all levels of care, acute crisis centers, residential drug rehabs and private practice settings:
Wide range of experience working with severe to mild psychopathology and most Axis and Axis II disorders.
Private Practice
Group Counseling including: Anger Management, Self Esteem, Psychopharmacology, Chemical Dependency and Cognitive
Restructuring, Progressive Relaxation, Depression, Anxiety,
Reducing Psychotic Symptoms
Pain Management
Case Management
Workers Compensation Evaluation
Sub investigator and Chief of Ratings for Clinical Trials
Crisis Interventions
Alcohol and Drug Prevention
Thorough knowledge of 12 step programs
Suicide Interventions in vivo and telephone
Domestic Violence Interventions
Social Service Planning
Intake Assessments
Discharge planning
Manage care consultations
Diagnosis and thorough Knowledge of the DSM-IV
Psychological Testing
Research Assessments and Ratings
Generating Effective Treatment Interventions
Individual Counseling
Medication Monitoring, Social Service Planning, Alcohol and Drug Prevention.
Consultation with professional agencies including: psychiatric facilities, hospitals, law enforcement, probation, Social Service, Child Protective Services, medical professionals.
Professional Experience:
Owner/Psychologist Advanced Psychological Systems 03/22/07- Current
Psychologist
Universal Psychiatric Medical Center 5/07-current
Psychologist
A Better Tomorrow Treatment Center 08/05/ to 5/07
Psychological Assistant
PSB 31615 George Tucker, Ph.D and A Better Tomorrow Treatment Center 08-05/ 02/17/07
Chief Rater/Sub- Investigator Optimum Health Services, La Mesa, CA 01-01/05-04
Psychological Assistant (PSB28812) David Marks M.D. /OHS/ Pacific Beach, CA 01-01/05-03
Needs Assessment Coordinator /Social Work Alvarado Parkway Institute, La Mesa, CA 02-00/ 01-01
Mental Health Counselor/intern Villa View Community Hospital, San Diego, CA 1999-2001
Mental Health Counselor Jerry Barreto Acute Crises Center San Diego, CA. 1997-1999
On Call Mental Health Counselor Halcyon Acute Crises Center, El Cajon, CA 1997-1998
Team Leader/Mental Health Counselor Jerry Barreto Acute Crisis Center, Logan Heights, CA 1994-1999
On Call Mental Health Counselor/Intern New Vistas Acute Crises Center, San Diego, CA 1993-1995
Music Therapist Family Service Center, Chico, CA 1992 (6months)
Case Manager Catalyst: Domestic Violence Shelter /Chico, CA 1991-1992
Research Assistant/Sub-Investigator Irwin Rosenfarb, Ph.D. USIU/San Diego, CA 1996-1997
Research Assistant//Rater F. J. Mcguigan Ph.D. USIU/San Diego, CA 1994-1997
Honors & Awards:
OHS August Recruitment Winner for Oy Contral Pharma gambling study (2002)
Certificate Of Appreciation for presenting at an international symposium
"work beyond borders" in Calatfia Mexico (10-2000)
National Honor Society in Psychology (10/31/1995)
Certificate of Achievement for completion of 1000 hr internship at New Vistas Psychiatric Center (1994)
Academic Publications:
Green, T, Loren. (2001) .The relationship between social anxiety and frequency of
interactions with primary social support in senior adults.
The Dissertation Database. Dissertation Abstracts Online. Dissertation Abstracts Ondisc (DAO). Proquest Digital Dissertations (PQDD). Dissertation Abstracts International. The Comprehensive Dissertation Index (CDI). American Doctoral Dissertations (ADD)
Academic Research Experience:
Primary Investigator
United States International University
2001 - Doctoral Psychology Dissertation of the relationship between social anxiety and frequency of interactions with primary social support in senior adults. The first study to find Social Phobia in the senior adult population.
Sub- Investigator
Stress Management Institute at United States International University
1994-1997 conducted and designed research with Nobel Laureate nominee F.J. Mcguigan Ph. D. For the company Musak. Investigated the psychological effects of music on stress.
Rater
United States International University
1996 - Research Assistant for Irwin Rosenfarb, Ph.D.: research on the relationship between stress and schizophrenia. Served as a rater with other raters and was part of an inter-rater reliability team.
Clinical Trial Research Experience:
Sub-Investigator, Chief Rater, Recruitment, Advertising, Coordinator #1
CPH-101-0600 Nalmefene in the Treatment of Pathological Gambling. A Placebo-Controlled Dose-Response Study: Oy Contral Pharma.
Sub-Investigator, Chief Rater, Advertising
Six-Week Double Blind The Efficacy and Safety of Three Dose Levels of SM-13496. Compared to Placebo and Haloperidol in Patients with Schizophrenia who are Experiencing an Acute Exacerbation of Symptoms. Sumitomo Pharmaceuticals America Ltd.
Sub-Investigator, Chief Rater
A long-term multicenter randomized, double blind, placebo-controlled study of Org 33062 ER in outpatient children and adolescents with attention deficit hyperactivity disorder and co morbid depression or anxiety. Organon.
Sub-Investigator, Chief Rater, Advertising, Recruitment
A multicenter, Double Blind, Randomized, Placebo controlled comparison of the effects on Sexual Functioning of Extended-release Bupropion Hydrochloride (300-450mg) and Escitalopram (10-20) in Outpatients with moderate to Severe Major Depression over an 8 week TX period. GlaxoSmithKline.
Sub-Investigator, Chief Rater, Recruitment
Pro. # A2721012. A Phase II, Twelve Week, Double Blind and Placebo Controlled Study to Evaluate the Safety and Efficacy of Two Doses of CP-448, 187 (1.5mg and 3.0mg) in Subjects wit6h Obsessive Compulsive Disorder. Pfizer.
Sub-Investigator, Chief Rater
A Phase II Double Blind, Randomized, Dose Ranging, Placebo Controlled, Multicenter, Safety and Efficacy Evaluation of Three Doses of NS 2330 In Patients with Mild to Moderate Dementia of the Alzheimer’s Type Protocol# 1198.52. Quintiles Transnational.
Sub-Investigator
The Effect of Ortho Tri-Cyclen on Bone Mineral Density in Pediatric Subjects with Anorexia Nervosa: A Double Blind, Placebo-Controlled Study Protocol Capss-169: Phase II. Pharmanet Inc.
Chief Rater, Advertising
Randomized, Open-Label, Dose-Blinded, Multicenter, 6-Month Study of Safety and Tolerability of 3 Dose Levels of M-13496 in Patients with Schizophrenia: Sumitomo Pharmaceuticals America Ltd.
Chief Rater, Advertising, Recruitment
Phase III, Three Week, Multicenter, Randomized, Double Blind, Placebo Controlled, Parallel-Group Safety and efficacy Study of Extended-Release Carbamazepine in the Treatment of Bipolar- I Disorder: Shire Pharmaceutical Development Inc.
Chief Rater, Advertising, Recruitment
A Multicenter, Double Blind, Randomized, Placebo-controlled, Double-dummy Trial of the Use of Quetiapine Fumarate (SeroquelTM) in the Treatment of Patients with Bipolar Depression. AstraZeneca
Rating Certifications and Qualifications:
SCID , PANSS , YMARS ,
SCI-PANSS , SOGS , SAS ,
IQ-PANNS , GSAS , PSQI-W ,
MADRS , AUDIT , K-SADS P-L ,
HAM-A , SCGI , ADHDRS ,
HAM-D , PGYBOX , CONNERS-P ,
CDRS-R , PARS , CGAS ,
K-BIT , STROOP , SDFQ ,
SARS , WAIS , WISC ,
MMPI , HTP , CGI
References:
George Tucker, Ph.D- 300881 Via Ultimo, San Juan Capistrano, Ca, 92675 949-842-2423
Charles Anderson- CEO of A BETTER TOMORROW- 951-551-6413
China Long, M.A. -951-694-0608
